[ad_1]
welcome to Business Insider‘s daily health bulletin, your daily dose of pharmaceutical, biotech and health news. Sign up here to receive this newsletter in your inbox every day of the week.
Hollis Johnson / Business Insider
Hello,
Boy, what a week it has been. I don’t know about you, but much of my waking time is spent thinking about the vaccine trials that are underway, the results we might get, and when life might start to feel completely “normal.”
We’ll go into everything we’ve learned about the vaccine race in a few, but if you haven’t already, be sure to subscribe here for your daily dose of health news from the Business Insider team.
Alex Wong / Getty Images; Drew Angerer / Getty Images; Mandel Ngan / AFP via Getty Images; Chip Somodevilla / Getty Images; Photo by Evan Vucci / AP
Dr. Fauci has not yet realized what he will do for the holidays.
This week, Insider’s senior health and science reporter, Hilary Brueck, had a conversation with Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases.
She packed a lot into a quick video chat, immersing herself in everything from:
Read the full interview here >>
Fauci’s Interview: How to ‘Keep Your Immune System Working Optimally’, Get Together Safely, and Survive Until Summer 2022
Nurse Kath Olmstead, right, gives volunteer Melissa Harting, of Harpersville, New York, an injection as the world’s largest study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc. ., begins Monday, July 27, 2020, in Binghamton, NY
AP Photo / Hans Pennink
We are still trying to find out if coronavirus vaccines work this fall
I feel like I’ve aged a decade since last Friday’s update on the status of the coronavirus vaccine race.
Saturday, UK AstraZeneca The vaccine trial was resumed, although the US trial is still on hiatus.
This week, Pfizer Executives also doubled down on the company’s claim that we will know if its vaccine works for Halloween.
During its investor day, Andrew Dunn reports, the pharmaceutical giant shared updates on its trial and what safety data will be needed to obtain emergency clearance for the vaccine.
Obtaining data before Halloween is certainly a difficult timeline that many experts don’t think is feasible.
Analysts at JPMorgan, for example, ran 10,000 simulations to get an idea of when we might know when a vaccine might work. They found there is a “low probability” of having coronavirus vaccine data in October.
Modern set his eyes on having data for November. Moderna slowed down its testing and even closed some testing locations to ensure diversity in the studio, CEO Stéphane Bancel told Andrew.
(Bancel also told Andrew that Moderna wants to make a flu shot, maybe even an injection that combines protection against flu and coronavirus)
There was so much vaccine news that it may have been missed that Eli Lilly presented his first human data on a new antibody drug to treat COVID-19. Lilly said Wednesday that the treatment showed promising results.
Read more about antibody drugs and why they could be key to fighting the pandemic here >>
Meanwhile, the US government is drawing up plans to bring the vaccine to Americans once there is one (or more) that works.
At a Senate subcommittee hearing, CDC Director Robert Redfield said that most Americans probably won’t get vaccinated until late spring or summer of next year, Aria Bendix reports.
Regardless of when a vaccine arrives, top health officials have a plan in hand, including details on who will get it first, when people expect to get their second shots, how the US will track where the vaccine is going, and plus.
Kimberly Leonard scanned the entire playbook.
Read their full story here >>
The United States just released a 57-page manual for all Americans to receive free coronavirus vaccines. Here are the 5 fundamental takeaways.
Amwell CEOs Roy and Ido Schoenberg.
Amwell
Virtual care companies are changing where we go to the doctor for checkups and tests
It was a great week in digital health, as telehealth company American Well made its debut in the public market on Thursday.
The company soared to a $ 5 billion valuation after its first day of trading, closing 28% higher than the previous night’s price.
It’s another reminder that the coronavirus pandemic is changing the way Americans engage with their healthcare. People are choosing to go online for doctor appointments, find ways to get tested at home, and monitor their health from devices like the Apple Watch.
Blake Dodge has been following this change since he joined us in March.
This week, he learned the inside story of how Vault Health, a men’s health startup that was taking off just before the pandemic, became a key test partner for 61 universities, SpaceX and the NBA.
Vault provides places like universities testing for coronavirus at home, in hopes of detecting cases before students arrive on campus.
You can read the full story here.
It also covered some of the healthcare developments announced at Apple’s event this week.
The Apple Watch’s new feature that monitors a user’s blood oxygen levels and the launch of a new fitness service suggest that Apple is digging into the $ 3.6 billion healthcare system.
Blake also closely followed Amwell’s initial public offering, identifying investors who would get the most out of it as the company went public. The list includes generic drug maker Teva and co-CEOs Roy and Ido Schoenberg.
Read the full story here >>
Telehealth company Amwell rose to a $ 5 billion valuation on its IPO. Here are the investors and executives you can make the most of.
Masked traders work, on the first day of in-person trading since the close during the coronavirus disease (COVID-19) outbreak on the floor of the New York Stock Exchange in New York.
Reuters
10 health stocks to buy, according to Morgan Stanley
I leave you with some news that you can use.
This week, Morgan Stanley unveiled a list of 10 health stocks to buy as we head into an election and a winter with the coronavirus pandemic.
The list includes everything from healthcare giants like UnitedHealth Group to new entrants like 10x Genomics.
Read the full story >>
Morgan Stanley selected the top 10 health stocks to buy now as investors gear up for a major pick and the possibility of another coronavirus surge
I hope everyone has a great weekend and a happy new year to those who celebrate!
See you next week! In the meantime, you can reach me at [email protected] and the entire healthcare team at [email protected].
– Lydia
